ArticleAmerican journal of translational research2025
A retrospective comparative study of helium-neon laser combined with ultrasonic debridement in improving healing of chronic non-healing wounds.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate the clinical value of ultrasonic debridement alone, helium-neon (He-Ne) laser therapy alone, and their combined use in the treatment of chronic non-healing wounds.
methodsA total of 272 patients with chronic non-healing wounds treated at Panzhihua Central Hospital between October 2023 and December 2024 were retrospectively selected and assigned to three groups according to treatment modality: a combined group (n=90, He-Ne laser and ultrasonic debridement), an ultrasonic debridement group (n=95, ultrasonic debridement alone), and a He-Ne laser group (n=87, He-Ne laser alone). Clinical indicators, including wound healing, Pressure Ulcer Scale for Healing (PUSH) scores, microbiological parameters, and visual analog scale (VAS) scores were assessed before treatment and at 4, 8, and 12 weeks after treatment. Adverse reactions during treatment and recurrence rates within six-month of follow-up were collected.
resultsThe combined group achieved better efficacy compared with the single-treatment groups at all assessment time points. At 12 weeks after treatment, the combined group demonstrated higher complete healing rates than the single-treatment groups (
conclusionThe combined application of He-Ne laser therapy and ultrasonic debridement provides significant advantages in managing chronic non-healing wounds. This approach effectively promotes wound healing, enhances bacterial clearance, alleviates pain, shortens treatment cycles, lowers recurrence risk, and reduces treatment-related adverse reactions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.